DIABETES RES CLIN PR:糖尿病显著增加抑郁风险

2013-01-06 DIABETES RES CLIN PR CMT 欧柏青 编译

  意大利的一项荟萃研究提示,糖尿病与抑郁风险显著增加相关。文章认为糖尿病与抑郁症相关的病理机制值得进一步探讨。相关论文2012年12月26日在线发表于《糖尿病研究与临床实践》杂志(Diabetes Research and Clinical Practice)。   该荟萃研究使用关键词“糖尿病和抑郁或糖尿病和抗抑郁药”检索Medline,选择那些

  意大利的一项荟萃研究提示,糖尿病与抑郁风险显著增加相关。文章认为糖尿病与抑郁症相关的病理机制值得进一步探讨。相关论文2012年12月26日在线发表于《糖尿病研究与临床实践》杂志(Diabetes Research and Clinical Practice)。

  该荟萃研究使用关键词“糖尿病和抑郁或糖尿病和抗抑郁药”检索Medline,选择那些评价有或无糖尿病的个体与抑郁症发生风险的纵向研究。共检索出1898项相关研究,其中16项纳入荟萃研究,包括497223个样本,平均随访5.8年,有42633例抑郁发作。与非糖尿病组相比,糖尿病组的受试者抑郁年发生率更高(1.4% vs 1.6%,p<0.001),未经校正和校正后的危险度分别为1.29(95%可信区间1.18-1.40,p<0.001)和1.25(95%可信区间1010-1.44,p=0.001)。

糖尿病相关的拓展阅读:


Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies

Aim

The present meta-analysis is aimed at the assessment of the risk of incident clinical depression and/or depressive symptoms in patients with diabetes.

Methods

A Medline search was performed on December 30th, 2011, using the search string: “diabetes AND (depression OR antidepressant)”, selecting longitudinal studies that assessed the risk of incident depression in subjects with or without diabetes. Study design and characteristics were verified for each study. A meta-analysis was performed for unadjusted and adjusted risk ratios of incident depression in subjects with diabetes using a random effect model. Additional analyses were performed to assess heterogeneity, publication bias and specific hazard ratios for several possible confounders.

Results

Of the 1898 retrieved studies, 16 were included in the meta-analysis, enrolling 497,223 subjects, with a mean follow-up of 5.8 years and 42,633 cases of incident depression. A higher incidence of depression was found in diabetic subjects (1.6% vs 1.4% yearly), with unadjusted and adjusted risk [95% confidence interval] of 1.29 [1.18–1.40] (p<0.001) and 1.25 [1.10–1.44] (p=0.001), respectively.

Conclusions

Diabetes is associated with a significantly increased risk for depressive symptoms. Pathogenetic mechanisms connecting diabetes with depression deserve further exploration.



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901044, encodeId=b1221901044a3, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759237, encodeId=b3b11e59237ef, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Mar 08 17:55:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636617, encodeId=a72b163661ef6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Oct 30 03:55:00 CST 2013, time=2013-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039692, encodeId=755920396923c, content=<a href='/topic/show?id=d0f554991f6' target=_blank style='color:#2F92EE;'>#抑郁风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54991, encryptionId=d0f554991f6, topicName=抑郁风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Aug 13 01:55:00 CST 2013, time=2013-08-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901044, encodeId=b1221901044a3, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759237, encodeId=b3b11e59237ef, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Mar 08 17:55:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636617, encodeId=a72b163661ef6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Oct 30 03:55:00 CST 2013, time=2013-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039692, encodeId=755920396923c, content=<a href='/topic/show?id=d0f554991f6' target=_blank style='color:#2F92EE;'>#抑郁风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54991, encryptionId=d0f554991f6, topicName=抑郁风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Aug 13 01:55:00 CST 2013, time=2013-08-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901044, encodeId=b1221901044a3, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759237, encodeId=b3b11e59237ef, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Mar 08 17:55:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636617, encodeId=a72b163661ef6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Oct 30 03:55:00 CST 2013, time=2013-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039692, encodeId=755920396923c, content=<a href='/topic/show?id=d0f554991f6' target=_blank style='color:#2F92EE;'>#抑郁风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54991, encryptionId=d0f554991f6, topicName=抑郁风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Aug 13 01:55:00 CST 2013, time=2013-08-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901044, encodeId=b1221901044a3, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759237, encodeId=b3b11e59237ef, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Mar 08 17:55:00 CST 2013, time=2013-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636617, encodeId=a72b163661ef6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Oct 30 03:55:00 CST 2013, time=2013-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039692, encodeId=755920396923c, content=<a href='/topic/show?id=d0f554991f6' target=_blank style='color:#2F92EE;'>#抑郁风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54991, encryptionId=d0f554991f6, topicName=抑郁风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Tue Aug 13 01:55:00 CST 2013, time=2013-08-13, status=1, ipAttribution=)]

相关资讯

Diabetes:软脂酸/油酸比例与女性糖尿病发病风险呈正相关

相对于富含软脂酸(PA)的食物,富含油酸(OA)的食物与降低2型糖尿病风险相关,但具体机制不明。为此,美国佛蒙特大学研究者Kien CL在年轻人中开展了一项饮食中脂质组学与胰岛素敏感性关系的研究(A Lipidomics Analysis of the Relationship Between Dietary Fatty Acid Composition and Insulin Sensitivi

PLoS Genet:面对2型糖尿病,胖瘦是否有区别?

体型肥胖者罹患2型糖尿病通常可以从胰岛素抵抗角度解释,然而为什么体型瘦弱的人同样会得糖尿病?2012年5月的PLoS Genet杂志上刊出了一篇论文就探寻了瘦人和胖人在2型糖尿病发病上的差异(PLoS Genet. 2012 May;8(5):e1002741)。 该研究旨在通过对2型糖尿病病例按BMI分层,来确认LAMA1基因的遗传风险变异,并发现瘦人体内更多的风险变异。毫无疑问,弄清楚瘦

Diabetes Care;肾病增高糖尿病视网膜病变风险

     非增生性糖尿病视网膜病和视网膜出血       增生性糖尿病视网膜病和新血管    2012年12月28日在线发表于《糖尿病护理》的一项研究表明,血糖控制、眼部以外并发症(肾病、未愈合溃疡)与糖尿病视网膜病变风险增高相关。视网膜病变进展风险评分可帮助临床医生对糖尿病眼底病变高风险患者进行分层。   该研究为一项回顾性队列研究,旨在对非增生性视网膜病变(NPD

PLoS One:联合生长因子抑制剂可减少糖尿病小鼠的视力损害

Figure 2. Intravitreal injection of betacellulin induces increased retinal haemorrhage and augmented retinal vascular permeability in normal and diabetic retinas. 12月17日旧金山,ClevelandClinic研究人员BelaA

BMC Cancer:糖尿病恶化乳腺癌患者预后

  《生物医学中心癌症》(BMC Cancer)杂志2012年12月26日在线发表的一项研究指出,既往未诊断出糖尿病的老年乳腺癌患者,其临床分期和死亡率更高。   该研究是一项基于Seer-medicare数据库的观察性队列研究。研究者利用来自Surveillance、Epidemiology和End Results-Medicare linked dat

Diabetes:尿蛋白质组学可用于早期诊断糖尿病肾病

糖尿病肾病(DN)是一种逐渐进展的肾脏疾病,由长期高血糖引起的糖尿病的重要并发症。在西方国家,糖尿病肾病是透析的最常见原因。早期发现糖尿病肾病或许能运用药物进行干预治疗,从而延迟或避免使用肾脏替代治疗。为此,德国研究者Zürbig P进行了一项关于运用尿蛋白质组学诊断糖尿病肾病的研究(Urinary Proteomics for Early Diagnosis in Diabetic Nephro